| Ident. | Authors (with country if any) | Title |
|---|
| 000091 (2021) |
Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran] | The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. |
| 000135 (2021) |
Baptiste Maille [France] ; Marie Wilkin [France] ; Matthieu Million [France] ; Noémie Rességuier [France] ; Frédéric Franceschi [France] ; Linda Koutbi-Franceschi [France] ; Jérôme Hourdain [France] ; Elisa Martinez [France] ; Maxime Zabern [France] ; Christophe Gardella [France] ; Hervé Tissot-Dupont [France] ; Jagmeet P. Singh [États-Unis] ; Jean-Claude Deharo [France] ; Laurent Fiorina [France] | Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study. |
| 000162 (2021) |
Subhrojyoti Bhowmick [Inde] ; Amit Dang [Inde] ; B N Vallish [Inde] ; Sumit Dang [États-Unis] | Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review. |
| 000180 (2021) |
Ilad Alavi Darazam [Iran] ; Shervin Shokouhi [Iran] ; Mohamad Amin Pourhoseingholi [Iran] ; Seyed Sina Naghibi Irvani [Iran] ; Majid Mokhtari [Iran] ; Minoosh Shabani [Iran] ; Mahdi Amirdosara [Iran] ; Parham Torabinavid [Iran] ; Maryam Golmohammadi [Iran] ; Sayedpayam Hashemi [Iran] ; Arsalan Azimi [Iran] ; Mohammad Hossein Jafarazadeh Maivan [Iran] ; Omidvar Rezaei [Iran] ; Alireza Zali [Iran] ; Mohammadreza Hajiesmaeili [Iran] ; Hadiseh Shabanpour Dehbsneh [Iran] ; Akram Hoseyni Kusha [Iran] ; Maryam Taleb Shoushtari [Iran] ; Negar Khalili [Iran] ; Azam Soleymaninia [Iran] ; Latif Gachkar [Iran] ; Ali Khoshkar [Iran] | Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial. |
| 000245 (2021) |
Jessica J. Bartoszko [Canada] ; Reed A C. Siemieniuk [Canada] ; Elena Kum [Canada] ; Anila Qasim [Canada] ; Dena Zeraatkar [Canada] ; Long Ge [République populaire de Chine] ; Mi Ah Han [Corée du Sud] ; Behnam Sadeghirad [Canada] ; Arnav Agarwal [Canada] ; Thomas Agoritsas [Canada, Suisse] ; Derek K. Chu [Canada] ; Rachel Couban [Canada] ; Andrea J. Darzi [Canada] ; Tahira Devji [Canada] ; Maryam Ghadimi [Canada] ; Kimia Honarmand [Canada] ; Ariel Izcovich [Argentine] ; Assem Khamis [Royaume-Uni] ; Francois Lamontagne [Canada] ; Mark Loeb [Canada] ; Maura Marcucci [Canada] ; Shelley L. Mcleod [Canada] ; Sharhzad Motaghi [Canada] ; Srinivas Murthy [Canada] ; Reem A. Mustafa [États-Unis] ; John D. Neary [Canada] ; Hector Pardo-Hernandez [Espagne] ; Gabriel Rada [Chili] ; Bram Rochwerg [Canada] ; Charlotte Switzer [Canada] ; Britta Tendal [Australie] ; Lehana Thabane [Canada] ; Per O. Vandvik [Norvège] ; Robin W M. Vernooij [Pays-Bas] ; Andrés Viteri-García [Chili, Équateur] ; Ying Wang [Canada] ; Liang Yao [Canada] ; Zhikang Ye [Canada] ; Gordon H. Guyatt [Canada] ; Romina Brignardello-Petersen [Canada] | Prophylaxis against covid-19: living systematic review and network meta-analysis. |
| 000310 (2021) |
Silvia Molino [Espagne] ; Andrea Pisarevsky [Argentine] ; Fabiana Lopez Mingorance [Argentine] ; Patricia Vega [Argentine] ; Juan Pablo Stefanolo [Argentine] ; Julieta Repetti [Argentine] ; Guillermina Ludue A [Argentine] ; Pablo Pepa [Argentine] ; Juan Ignacio Olmos [Argentine] ; Marcelo Rodriguez Fermepin [Argentine] ; Tatiana Uehara [Argentine] ; Sonia Villapol [États-Unis] ; Tor Savidge [États-Unis] ; Todd Treangen [États-Unis] ; Elisa Viciani [Italie] ; Andrea Castagnetti [Italie] ; Maria Marta Piskorz [Argentine] | Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial. |
| 000368 (2021) |
Sophie Juul [Danemark] ; Emil Eik Nielsen [Danemark] ; Joshua Feinberg [Danemark] ; Faiza Siddiqui [Danemark] ; Caroline Kamp J Rgensen [Danemark] ; Emily Barot [Danemark] ; Johan Holgersson [Suède] ; Niklas Nielsen [Suède] ; Peter Bentzer [Suède] ; Areti Angeliki Veroniki [Grèce, Canada] ; Lehana Thabane [Canada] ; Fanlong Bu [République populaire de Chine] ; Sarah Klingenberg [Danemark] ; Christian Gluud [Danemark] ; Janus Christian Jakobsen [Danemark] | Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). |
| 000424 (2021) |
Petri J. Vainio [Finlande] ; Pauliina Hietasalo [Finlande] ; Anna-Liisa Koivisto [Finlande] ; Susanna K Ri Inen [Finlande] ; Jari Turunen [Finlande] ; Mika Virtala [Finlande] ; Jouni Vuorinen [Finlande] ; Mika Scheinin [Finlande] | Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. |
| 000524 (2021) |
Amirreza Roostaei Firozabad [Iran] ; Zohreh Akhoundi Meybodi [Iran] ; Seyed Ruhollah Mousavinasab [Iran] ; Adeleh Sahebnasagh [Iran] ; Mohsen Gholinataj Jelodar [Iran] ; Iman Karimzadeh [Iran] ; Solomon Habtemariam [Royaume-Uni] ; Fatemeh Saghafi [Iran] | Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial. |
| 000525 (2021) |
Benjamin S. Abella [États-Unis] ; Eliana L. Jolkovsky [États-Unis] ; Barbara T. Biney [États-Unis] ; Julie E. Uspal [États-Unis] ; Matthew C. Hyman [États-Unis] ; Ian Frank [États-Unis] ; Scott E. Hensley [États-Unis] ; Saar Gill [États-Unis] ; Dan T. Vogl [États-Unis] ; Ivan Maillard [États-Unis] ; Daria V. Babushok [États-Unis] ; Alexander C. Huang [États-Unis] ; Sunita D. Nasta [États-Unis] ; Jennifer C. Walsh [États-Unis] ; E Paul Wiletyo [États-Unis] ; Phyllis A. Gimotty [États-Unis] ; Michael C. Milone [États-Unis] ; Ravi K. Amaravadi [États-Unis] | Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. |
| 000544 (2021) |
Gilmar Reis [Brésil] ; Eduardo Augusto Dos Santos Moreira Silva [Brésil] ; Daniela Carla Medeiros Silva [Brésil] ; Lehana Thabane [Canada] ; Gurmit Singh [Canada] ; Jay J H. Park [Canada] ; Jamie I. Forrest [Canada] ; Ofir Harari [Canada] ; Castilho Vitor Quirino Dos Santos [Brésil] ; Ana Paula Figueiredo Guimarães De Almeida [Brésil] ; Adhemar Dias De Figueiredo Neto [Brésil] ; Leonardo Cançado Monteiro Savassi [Brésil] ; Aline Cruz Milagres [Brésil] ; Mauro Martins Teixeira [Brésil] ; Maria Izabel Campos Simplicio [Brésil] ; Luciene Barra Ribeiro [Brésil] ; Rosemary Oliveira [Brésil] ; Edward J. Mills [Canada] | Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial. |
| 000565 (2021) |
Iwein Gyselinck [Belgique] ; Laurens Liesenborghs [Belgique] ; Ewout Landeloos [Belgique] ; Ann Belmans [Belgique] ; Geert Verbeke [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] ; W. Janssens [Belgique] | Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial. |
| 000616 (2021) |
Rosemarie De Souza [Oman] ; Sharayu Mhatre [Inde] ; Burhanuddin Qayyumi [Inde] ; Garvit Chitkara [Inde] ; Tushar Madke [Inde] ; Mohan Joshi [Inde] ; Ramesh Bharmal [Inde] ; D S Asgaonkar [Inde] ; Prem Lakhani [Inde] ; Sudeep Gupta [Inde] ; Pankaj Chaturvedi [Inde] ; Rajesh Dikshit [Inde] ; Rajendra Badwe [Inde] | Clinical course and outcome of patients with COVID-19 in Mumbai City: an observational study. |
| 000710 (2021) |
Jose Luis Rodriguez-Garcia ; Gines Sanchez-Nievas ; Juan Arevalo-Serrano ; Cristina Garcia-Gomez ; Jose Maria Jimenez-Vizuete ; Elisa Martinez-Alfaro [Espagne] | Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study. |
| 000741 (2021) |
Álvaro Réa-Neto [Brésil] ; Rafaella Stradiotto Bernardelli [Brésil] ; Bruna Martins Dzivielevski Câmara [Brésil] ; Fernanda Baeumle Reese [Brésil] ; Marcos Vinicius Oliveira Queiroga [Brésil] ; Mirella Cristine Oliveira [Brésil] | An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients. |
| 000A28 (2020) |
A B Bayoumy [Pays-Bas] ; N K H. De Boer [Pays-Bas] ; A R Ansari [Royaume-Uni] ; F. Crouwel [Pays-Bas] ; C J J. Mulder [Pays-Bas] | Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspective. |
| 000A42 (2020) |
José Meneses Calder N [Mexique] ; Hugo Mendieta Zer N [Espagne, Mexique] ; Srivatsan Padmanabhan [États-Unis] | Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. |
| 000B55 (2020) |
Justin T. Denholm [Australie] ; Joshua Davis [Australie] ; David Paterson [Australie] ; Jason Roberts [Australie, France] ; Susan Morpeth [Nouvelle-Zélande] ; Thomas Snelling [Australie] ; Dominica Zentner [Australie] ; Megan Rees [Australie] ; Matthew O'Sullivan [Australie] ; David Price [Australie] ; Asha Bowen [Australie] ; Steven Y C. Tong [Australie] | The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. |
| 000B95 (2020) |
Farzaneh Dastan [Iran] ; Seyed Alireza Nadji [Iran] ; Ali Saffaei [Iran] ; Majid Marjani [Iran] ; Afshin Moniri [Iran] ; Hamidreza Jamaati [Iran] ; Seyed Mohammadreza Hashemian [Iran] ; Parvaneh Baghaei [Iran] ; Atefeh Abedini [Iran] ; Mohammad Varahram [Iran] ; Sahar Yousefian [Iran] ; Payam Tabarsi [Iran] | Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. |
| 000C43 (2020) |
Ashkan Emadi [États-Unis] ; Joel V. Chua [États-Unis] ; Rohit Talwani [États-Unis] ; S Ren M. Bentzen [États-Unis] ; John Baddley [États-Unis] | Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. |
| 000C78 (2020) |
Jennifer C E. Lane [Royaume-Uni] ; James Weaver [États-Unis] ; Kristin Kostka [États-Unis] ; Talita Duarte-Salles [Espagne] ; Maria Tereza F. Abrahao [Brésil] ; Heba Alghoul ; Osaid Alser [États-Unis] ; Thamir M. Alshammari [Arabie saoudite] ; Carlos Areia [Royaume-Uni] ; Patricia Biedermann [Suisse] ; Juan M. Banda [États-Unis] ; Edward Burn [Royaume-Uni, Espagne] ; Paula Casajust [Espagne] ; Kristina Fister [Croatie] ; Jill Hardin [États-Unis] ; Laura Hester [États-Unis] ; George Hripcsak [États-Unis] ; Benjamin Skov Kaas-Hansen [Danemark] ; Sajan Khosla [Royaume-Uni] ; Spyros Kolovos [Royaume-Uni] ; Kristine E. Lynch [États-Unis] ; Rupa Makadia [États-Unis] ; Paras P. Mehta [États-Unis] ; Daniel R. Morales [Royaume-Uni] ; Henry Morgan-Stewart [États-Unis] ; Mees Mosseveld [Pays-Bas] ; Danielle Newby [Royaume-Uni] ; Fredrik Nyberg [Suède] ; Anna Ostropolets [États-Unis] ; Rae Woong Park [Corée du Sud] ; Albert Prats-Uribe [Royaume-Uni] ; Gowtham A. Rao [États-Unis] ; Christian Reich [États-Unis] ; Peter Rijnbeek [Pays-Bas] ; Anthony G. Sena [États-Unis, Pays-Bas] ; Azza Shoaibi [États-Unis] ; Matthew Spotnitz [États-Unis] ; Subbian Vignesh [États-Unis] ; Marc A. Suchard [États-Unis] ; David Vizcaya [Espagne] ; Haini Wen [République populaire de Chine] ; Marcel De Wilde [Pays-Bas] ; Junqing Xie [Royaume-Uni] ; Seng Chan You [Corée du Sud] ; Lin Zhang [République populaire de Chine, Australie] ; Simon Lovestone [Royaume-Uni] ; Patrick Ryan [États-Unis] ; Daniel Prieto-Alhambra [Royaume-Uni] | Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. |
